Le Lézard
Classified in: Health, Business, Sports and recreation
Subjects: NPT, ECO

Ride for Cancer announces $579,234 raised and counting


NOTE TO EDITORS: Video and photo opportunities of Ride for Cancer participants crossing finish line today between 4:00 p.m. and 5:00 p.m. at LED Roadway Lighting, 115 Chain Lake Drive, Halifax. Interview opportunities with participants, who've cycled 25, 50, 100 or 130 kilometres for cancer care, are also available.

HALIFAX, Sept. 30, 2017 /CNW/ - Ride for Cancer, Atlantic Canada's largest one-day fundraising cycling event, hosted in partnership by the QEII Foundation and The Leukemia & Lymphoma Society of Canada, announced today that more than 475 riders helped raise $579,234 net for local cancer care. And that number is still rising.

Ride for Cancer announces $579,234 raised and counting! (CNW Group/QEII Foundation)

Since the event began three years ago, Ride for Cancer has raised more than $1-million.

Today, riders will embark on an epic journey spanning 130 kilometres from Mahone Bay to Halifax ? all in support of Atlantic Canadians battling cancer. Presenting sponsor of Ride for Cancer for the third year in a row, BMO Bank of Montreal has played an integral role in the success of the annual cycling event.

"Our entire Ride for Cancer community is amazing ? the riders and their networks who donated to them, our many sponsors, and volunteers have made this event a major success," says Joe DiPenta, Regional Director, Atlantic Canada and National Director of The Leukemia and Lymphoma Society of Canada. "Together, we are making a big impact on cancer care in our region."

Funds raised from the 2017 Ride for Cancer event will purchase advanced cancer therapy preparation equipment for the QEII Health Sciences Centre, support local blood cancer research, and fund patient and family support programs through The Leukemia and Lymphoma Society of Canada.  

In Atlantic Canada, more than 15,000 individuals are diagnosed with cancer each year. And approximately 50 per cent of those individuals will require some form of chemotherapy.

"By funding new cancer therapy preparation equipment at the QEII Health Sciences Centre, we are doubling capacity and shortening wait times for cancer patients," says Bill Bean, President and CEO of the QEII Foundation. "Seeing participants, many of whom are cancer survivors or currently battling the disease, pushing themselves and joining together for a cause that touches us all, is so incredibly powerful."

Cyclists commit to fundraise and ride one of five distance options via the Rum Runners Trail (25, 50 or 100 kilometres) or via road (100 or 130 kilometres). This one-of-a-kind cycling event, that includes both trail and road components, brings together veterans of the cycling community, recreational and rookie riders and even those participating virtually.

Powered by BMO Bank of Montreal, Ride for Cancer participants will complete their respective journeys at LED Roadway Lighting in Halifax. The all-day finish celebration is open to the public and includes a food truck rally, live bands and entertainment.

To learn more about the impact of the 2017 Ride for Cancer, make a general donation or sponsor a team or participant, visit YourRideForCancer.ca.

 

SOURCE QEII Foundation


These press releases may also interest you

at 20:25
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...

at 20:12
BCACC is pleased to announce that its Deputy Registrar, Kathy Lauriente, has been honoured with the Distinguished Service Award from Thompson Rivers University. The award recognizes stellar contributions to the University, community, and the public...

at 19:29
Suffolk DBT is proud to announce the completion of their initial expansion to accommodate the growing need for DBT therapy...

at 18:24
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...

at 17:55
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....

at 17:43
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...



News published on and distributed by: